DoW Peer Reviewed Medical, Technology/Therapeutic Development Award
About
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award, a product-driven award mechanism, intends to support the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals. Products can be tangible items, such as drugs or devices, or can be knowledge products, such as clinical decision-making tools or practice guidelines. Products in development should address or have dual purpose potential for the health care needs of military Service Members, Veterans and their Families. Distinctive Features: For the PRMRP Technology/Therapeutic Development Award, the program expects the research proposed will take an already established proof-of-concept or prototype through the final stages of preclinical development. The PRMRP also expects that the research outcome will be a regulatory filing or translation of findings into clinical practice, as applicable. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $67.2M to fund approximately 12 Technology/Therapeutic Development Award applications with total cost caps of $5.6M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 fun.
The DoW Peer Reviewed Medical, Technology/Therapeutic Development Award is a federal grant program designed for researchers and organizations ready to translate promising preclinical medical research into real-world products and clinical applications. This award mechanism supports the development of tangible products—such as pharmaceuticals and medical devices—as well as knowledge products like clinical decision-making tools and practice guidelines. The program is particularly valuable for innovators working on solutions for disease prevention, detection, diagnosis, treatment, or quality-of-life improvements related to congressionally prioritized health topics. A distinctive feature of this award is its focus on taking already-established proof-of-concept or prototype research through final preclinical development stages, with the expectation that funded projects will result in regulatory filings or translation into clinical practice. The program particularly welcomes research addressing the healthcare needs of military Service Members, Veterans, and their families. With funding of up to $5.6 million per award over a maximum four-year period, this grant is ideal for research teams and entrepreneurs positioned to bridge the gap between laboratory innovation and patient care, especially those with dual-use applications benefiting military and veteran populations.
Funding Facts
● Applications openDeadline
August 6, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Up to $5.6 million per award
Deadline
2026-08-06
Grant Type
federal
Application Cycle
Annual (FY26 deadline: August 6, 2026)
Best For
Research institutions, academic centers, and organizations translating preclinical medical research into clinical products and therapeutics for military Service Members, Veterans, and their families
Frequently Asked Questions
Who is eligible for the DoW Peer Reviewed Medical, Technology/Therapeutic Development Award?
Specific eligibility criteria were not provided in the available program information. Eligible applicants typically include research institutions, universities, nonprofit organizations, and other entities conducting medical research. For complete and current eligibility requirements, including any restrictions on organization type, applicant qualifications, and citizenship status, please visit the official Congressionally Directed Medical Research Programs (CDMRP) website or contact the program directly.
How much funding does the DoW Peer Reviewed Medical, Technology/Therapeutic Development Award provide?
Individual awards can reach up to $5.6 million in total costs. The FY26 funding cycle expects to allocate approximately $67.2 million across approximately 12 Technology/Therapeutic Development Award applications. The maximum period of performance is 4 years. Award amounts may vary by funding cycle, so check the official CDMRP website for current fiscal year details.
What is the application deadline for the DoW Peer Reviewed Medical, Technology/Therapeutic Development Award?
The FY26 application deadline is August 6, 2026. Application deadlines vary by funding cycle. For upcoming deadlines and to confirm the current application window, visit the official CDMRP website.
What can DoW Peer Reviewed Medical, Technology/Therapeutic Development Award funding be used for?
This award funds research that translates established proof-of-concept or prototype findings into products ready for clinical application. Eligible products include drugs, medical devices, clinical decision-making tools, and practice guidelines. Research must address disease prevention, detection, diagnosis, treatment, or quality-of-life improvements related to FY26 PRMRP topic areas. Projects should target health needs of military Service Members, Veterans, and their families, with preference for solutions with dual-purpose applications. The expected outcome is a regulatory filing or translation of findings into clinical practice.
How do I apply for the DoW Peer Reviewed Medical, Technology/Therapeutic Development Award?
The application process is managed through the Congressionally Directed Medical Research Programs (CDMRP). Visit the official CDMRP website to access detailed application instructions, submission portals, required forms, and program guidelines. Applications typically require documentation of your research team, institutional support, project timeline, budget justification, and regulatory pathway plans. Ensure your proposed research aligns with current FY26 PRMRP topic areas and strategic goals before applying.
Last updated: July 5, 2026